Tech Blog

Cherry Biotech

Last verified 2026-05-02. JSON

The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.

Total raised$2.7Mattributed
Latest roundgrant, $2.7M, 2024-09-01attributed
Foundedunknown
HeadquartersParis, France
Industrybiotech
Stageunknown
Websitecherrybiotech.com

3D cell-culture and organoid platforms — organ-on-chip, ready-to-use organoid plates, and standardized spheroid kits. Sold to pharma and CROs replacing animal testing in preclinical work. Microfluidic perfusion gives more in-vivo-like data than static plates.

Funding rounds

DateRoundAmountLead
2024-09-01grant$2.7Mundisclosed

Detected tech stack

PHP 8.3, WordPress 7.0, Astra 4.6.13, Magnific Popup 3.9.3, Yoast SEO 27.5, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.7, PayU Payment, DoubleClick Floodlight, Cloudflare Browser Insights

Provenance

FactStatusBasis
Grant, $2.7Mattributedeu-grant named as publisher. No document URL on file.
Total raised $2.7Mattributedeu-grant named as publisher. No document URL on file.
Company existenceself-reportedcherrybiotech.com, read 2026-05-02
Descriptionself-reportedcherrybiotech.com, read 2026-05-02

Nothing on this page is sourced yet. A sourced fact links to a document that states it.

Change history

No change recorded since records began on 2026-09-24.